| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |